CN1352977A - 一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 - Google Patents
一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 Download PDFInfo
- Publication number
- CN1352977A CN1352977A CN 00133585 CN00133585A CN1352977A CN 1352977 A CN1352977 A CN 1352977A CN 00133585 CN00133585 CN 00133585 CN 00133585 A CN00133585 A CN 00133585A CN 1352977 A CN1352977 A CN 1352977A
- Authority
- CN
- China
- Prior art keywords
- ginsenoside
- formula
- glu
- production technology
- during
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title abstract description 7
- 230000001093 anti-cancer Effects 0.000 title abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 238000009835 boiling Methods 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 238000002347 injection Methods 0.000 claims abstract description 4
- 239000007924 injection Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 3
- 238000005516 engineering process Methods 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- YEZWWUMWIFKEQM-UHFFFAOYSA-N O.OC.ClC(Cl)Cl.CCOC(C)=O Chemical compound O.OC.ClC(Cl)Cl.CCOC(C)=O YEZWWUMWIFKEQM-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 150000008130 triterpenoid saponins Chemical class 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000208340 Araliaceae Species 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- -1 Feldalat KM Chemical compound 0.000 claims description 4
- 241000180649 Panax notoginseng Species 0.000 claims description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000010898 silica gel chromatography Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 2
- 238000005815 base catalysis Methods 0.000 claims description 2
- 230000003292 diminished effect Effects 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229940126534 drug product Drugs 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 abstract description 6
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 abstract 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 11
- 229930182490 saponin Natural products 0.000 description 11
- 150000007949 saponins Chemical class 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930182494 ginsenoside Natural products 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 2
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000010454 Experimental Liver Neoplasms Diseases 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001335855A CN100343270C (zh) | 2000-11-15 | 2000-11-15 | 一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001335855A CN100343270C (zh) | 2000-11-15 | 2000-11-15 | 一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101405698A Division CN101121743B (zh) | 2000-11-15 | 2000-11-15 | 一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1352977A true CN1352977A (zh) | 2002-06-12 |
CN100343270C CN100343270C (zh) | 2007-10-17 |
Family
ID=4595824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001335855A Expired - Fee Related CN100343270C (zh) | 2000-11-15 | 2000-11-15 | 一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100343270C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004054595A1 (fr) * | 2002-12-13 | 2004-07-01 | Dalian Institute Of Chemical Physics | Procede de preparation de ginsenoside a faible polarite et son aglucone de ginsenoside par pyrolyse catalytique |
CN100391468C (zh) * | 2006-02-27 | 2008-06-04 | 杭州创新中药标准化研究所有限公司 | 原人参二醇冻干乳剂及其制备方法 |
CN102125574A (zh) * | 2011-01-26 | 2011-07-20 | 吉林大学 | 用于抑制肿瘤的药物组合物 |
CN105287611A (zh) * | 2014-06-27 | 2016-02-03 | 江苏命码生物科技有限公司 | 人参皂苷Rh2在抑制Treg细胞中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR940004066B1 (ko) * | 1991-09-20 | 1994-05-11 | 재단법인 한국인삼연초연구소 | 인삼 성분으로부터 20(r & s) 진세노사이드를 제조하는 방법 |
KR940008291B1 (ko) * | 1991-09-20 | 1994-09-10 | 재단법인 한국인삼연초연구소 | 신물질 20(R)-전세노사이드 Rh₂ |
CN1091448C (zh) * | 1998-02-05 | 2002-09-25 | 沈阳天马医药科技开发有限公司 | 20(S)-人参皂甙-Rh2的制备 |
CN1122042C (zh) * | 2000-10-10 | 2003-09-24 | 海南亚洲制药有限公司 | 稀有人参皂甙的制备方法 |
-
2000
- 2000-11-15 CN CNB001335855A patent/CN100343270C/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004054595A1 (fr) * | 2002-12-13 | 2004-07-01 | Dalian Institute Of Chemical Physics | Procede de preparation de ginsenoside a faible polarite et son aglucone de ginsenoside par pyrolyse catalytique |
CN100391468C (zh) * | 2006-02-27 | 2008-06-04 | 杭州创新中药标准化研究所有限公司 | 原人参二醇冻干乳剂及其制备方法 |
CN102125574A (zh) * | 2011-01-26 | 2011-07-20 | 吉林大学 | 用于抑制肿瘤的药物组合物 |
CN105287611A (zh) * | 2014-06-27 | 2016-02-03 | 江苏命码生物科技有限公司 | 人参皂苷Rh2在抑制Treg细胞中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100343270C (zh) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017133465A1 (zh) | 一种黄芩苷镁化合物及其制备方法与它的用途 | |
CN111349017B (zh) | 一种从金钗石斛中提取化合物的工艺及应用 | |
US20050287230A1 (en) | Method of producing ginsenoside 20 (R)-Rh2 and composition of matter thereof | |
CN1352977A (zh) | 一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 | |
CN1061986C (zh) | 人参分组皂甙的制备方法,其药物组合物及应用 | |
CN110218262B (zh) | 褐藻来源的富含葡萄糖醛酸的低硫酸化杂聚糖在制备治疗2型糖尿病药物中的应用 | |
CN102875615B (zh) | 大麻药苷a和大麻药总皂苷的提取方法及其应用 | |
CN1225366A (zh) | 20(S)-人参皂甙-Rh2的制备方法,其药物组合物及应用 | |
CN101121743B (zh) | 一种从天然植物中提取治疗恶性肿瘤产品的生产工艺 | |
CN101220063B (zh) | 梓醇的制备新方法和含它的药物组合物及用途 | |
CN1199981C (zh) | 一种新药黄芩甙锌 | |
CN113797146A (zh) | 一种金钗石斛提取物及其制备方法与应用 | |
CN109303785B (zh) | 一种党参炔苷类似化合物在制备治疗心率失常药物中的应用 | |
CN107213176B (zh) | 一种八仙花叶提取物及其药物组合物、制备方法和应用 | |
CN100486988C (zh) | 一种20(R)—人参皂苷Rh2的制备方法 | |
CN107082780B (zh) | 一种具有吡咯骈异喹啉结构的生物碱及其制备方法与应用 | |
CN1171896C (zh) | 紫丁香总皂苷提取物及其制备方法及其药物组合物 | |
CN1170562C (zh) | 治疗癣疾的制剂 | |
CN1275978C (zh) | 澳洲茄胺盐酸盐的制备方法 | |
CN113444136B (zh) | 一种抗乳腺癌的乙型强心苷的制备及其抗肝癌应用 | |
CN110950921B (zh) | 一种三萜皂苷类化合物及其制备方法和应用 | |
DE19600301A1 (de) | Bioregulatorischer Wirkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung | |
CN116509921B (zh) | 米团花二倍半萜提取物k01在制备治疗脓毒血症的药物中的应用 | |
CN103641688B (zh) | 脉络宁二氢蒽及其制备方法和用途 | |
CN112920146B (zh) | 倍半萜类化合物及其制备方法和在制备抗炎药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LUYE NATURAL MEDICINAL RESEARCH DEVELOPING CO., L Free format text: FORMER OWNER: YILONG PHARMACEUTICAL CO LTD, SHENYANG Effective date: 20040611 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20040611 Address after: 264003, No. 9, Po Yuen Road, Laishan District, Shandong, Yantai Applicant after: Luye Natural Medicinal Research Developing Co., Ltd., Shandong Prov. Address before: Wenhua Road 110003 Liaoning city of Shenyang province No. 58 Liaozhan Hotel Room 408 Applicant before: Yilong Pharmaceutical Co Ltd, Shenyang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170608 Address after: 264670, No. 15, pioneering Road, hi tech Zone, Shandong, Yantai Patentee after: Shandong Luye Pharma Co., Ltd. Address before: 264003 Laishan, Shandong Province Bao Road, No. 9 District, No. Patentee before: Luye Natural Medicinal Research Developing Co., Ltd., Shandong Prov. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180131 Address after: No. 458, Zhifu District, Zhifu District, Shandong Province, Shanghai Patentee after: Shandong Tong Yu Tang ginseng Technology Co., Ltd. Address before: 264670, No. 15, pioneering Road, hi tech Zone, Shandong, Yantai Patentee before: Shandong Luye Pharma Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071017 Termination date: 20191115 |
|
CF01 | Termination of patent right due to non-payment of annual fee |